MedTrace Logo

Exergaming in People With Major Neurocognitive Disorder

NCT04436302 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-18

No results posted yet for this study

Summary

This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities.

Conditions

  • Randomised Controlled Trial
  • Major Neurocognitive Disorder
  • Long-term Care Facility
  • Physical Activity
  • Cognitive Impairment

Interventions

DEVICE

Exergame device

motor-cognitive training

Sponsors & Collaborators

  • Davy Vancampfort

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04436302 on ClinicalTrials.gov